{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:08:52Z","timestamp":1791310132696,"version":"4.3.1"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,1,30]],"date-time":"2014-01-30T00:00:00Z","timestamp":1391040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.jaut.2014.01.033","type":"journal-article","created":{"date-parts":[[2014,2,19]],"date-time":"2014-02-19T05:45:32Z","timestamp":1392788732000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":123,"special_numbering":"C","title":["Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: What is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants"],"prefix":"10.1016","volume":"50","author":[{"given":"S. Sohail","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Schur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noni E.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Steinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2014.01.033_bib1","series-title":"Enhanced monitoring of vaccine safety for 2009 pandemic vaccines","author":"European Center for Disease Prevention and Control","year":"2013"},{"key":"10.1016\/j.jaut.2014.01.033_bib2","series-title":"Approved products: influenza A (H1N1) 2009 monovalent","author":"U.S.Food and Drug Administration","year":"2010"},{"issue":"6","key":"10.1016\/j.jaut.2014.01.033_bib3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF03403962","article-title":"Influenza pandemic planning and performance in Canada, 2009","volume":"101","author":"Kendal","year":"2010","journal-title":"Can J Public Health"},{"key":"10.1016\/j.jaut.2014.01.033_bib4","series-title":"Drugs and health products: influenza A (H1N1) 2009 pandemic monovalent vaccine (without adjuvant)","author":"GlaxoSmithKline Inc","year":"2013"},{"key":"10.1016\/j.jaut.2014.01.033_bib5","series-title":"Narcolepsy in association with pandemic influenza vaccination (a multi-country European epidemiological investigation). Stockholm","author":"European Centre for Disease Prevention and Control","year":"2012"},{"issue":"93","key":"10.1016\/j.jaut.2014.01.033_bib6","doi-asserted-by":"crossref","first-page":"93rv2","DOI":"10.1126\/scitranslmed.3002302","article-title":"Assessing the safety of adjuvanted vaccines","volume":"3","author":"Ahmed","year":"2011","journal-title":"Sci Transl Med"},{"issue":"19","key":"10.1016\/j.jaut.2014.01.033_bib7","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1016\/j.vaccine.2011.06.009","article-title":"A\u00a0collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and Denmark","volume":"30","author":"Andrews","year":"2012","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.jaut.2014.01.033_bib8","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1542\/peds.99.6.765","article-title":"Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team","volume":"99","author":"Chen","year":"1997","journal-title":"Pediatrics"},{"issue":"39","key":"10.1016\/j.jaut.2014.01.033_bib9","article-title":"ECDC in collaboration with the VAESCO consortium to develop a complementary tool for vaccine safety monitoring in Europe","volume":"14","year":"2009","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jaut.2014.01.033_bib10","series-title":"The MPA investigates reports of narcolepsy in patients vaccinated with Pandemrix","author":"Lakemedelsverket Medical Products Agency","year":"2010"},{"issue":"3","key":"10.1016\/j.jaut.2014.01.033_bib11","doi-asserted-by":"crossref","first-page":"e33536","DOI":"10.1371\/journal.pone.0033536","article-title":"AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland","volume":"7","author":"Nohynek","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jaut.2014.01.033_bib12","doi-asserted-by":"crossref","first-page":"e33723","DOI":"10.1371\/journal.pone.0033723","article-title":"Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland","volume":"7","author":"Partinen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2014.01.033_bib13","series-title":"Association of receipt of Pandemrix and narcolepsy in children and adolescents in the UK (England)","author":"European Centre for Disease Prevention and Control","year":"2013"},{"key":"10.1016\/j.jaut.2014.01.033_bib14","doi-asserted-by":"crossref","first-page":"f794","DOI":"10.1136\/bmj.f794","article-title":"Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A\/H1N1 2009 influenza vaccine: retrospective analysis","volume":"346","author":"Miller","year":"2013","journal-title":"Br Med J"},{"key":"10.1016\/j.jaut.2014.01.033_bib15","series-title":"Registry study confirms increased risk of narcolepsy after vaccination with Pandemrix in children and adolescents and shows an increased risk in young adults","author":"Persson","year":"2013"},{"issue":"14","key":"10.1016\/j.jaut.2014.01.033_bib16","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1212\/WNL.0b013e31828ab26f","article-title":"Increased childhood incidence of narcolepsy in western Sweden after H1N1 influenza vaccination","volume":"80","author":"Szakacs","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2014.01.033_bib17","article-title":"Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action","author":"Barker","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jaut.2014.01.033_bib18","series-title":"GSK flu shot may raise adult narcolepsy risk: Finnish scientists","author":"Ando","year":"2013"},{"key":"10.1016\/j.jaut.2014.01.033_bib19","series-title":"Increased risk of narcolepsy observed also among adults vaccinated with Pandemrix in Finland","author":"Jokinen","year":"2013"},{"issue":"5","key":"10.1016\/j.jaut.2014.01.033_bib20","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/jsr.12044","article-title":"Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study","volume":"22","author":"Luca","year":"2013","journal-title":"J\u00a0Sleep Res"},{"issue":"9197","key":"10.1016\/j.jaut.2014.01.033_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","article-title":"Hypocretin (orexin) deficiency in human narcolepsy","volume":"355","author":"Nishino","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2014.01.033_bib22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaut.2013.02.003","article-title":"Genetic association, seasonal infections and autoimmune basis of narcolepsy","volume":"43","author":"Singh","year":"2013","journal-title":"J\u00a0Autoimmun"},{"issue":"3","key":"10.1016\/j.jaut.2014.01.033_bib23","first-page":"207","article-title":"A\u00a0hundred years of narcolepsy research","volume":"139","author":"Mignot","year":"2001","journal-title":"Arch Ital Biol"},{"key":"10.1016\/j.jaut.2014.01.033_bib24","series-title":"Narcolepsy","author":"Lancet communication","year":"1888"},{"issue":"9","key":"10.1016\/j.jaut.2014.01.033_bib25","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A\u00a0mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.jaut.2014.01.033_bib26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/sleep\/30.1.13","article-title":"The epidemiology of narcolepsy","volume":"30","author":"Longstreth","year":"2007","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.jaut.2014.01.033_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/sleep\/25.2.197","article-title":"The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study","volume":"25","author":"Silber","year":"2002","journal-title":"Sleep"},{"issue":"4","key":"10.1016\/j.jaut.2014.01.033_bib28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1600-0404.2007.00930.x","article-title":"Prevalence of narcolepsy-cataplexy in Korean adolescents","volume":"117","author":"Shin","year":"2008","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"10.1016\/j.jaut.2014.01.033_bib29","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/sleep\/34.5.627","article-title":"Presentations of primary hypersomnia in Chinese children","volume":"34","author":"Han","year":"2011","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.jaut.2014.01.033_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.sleep.2003.06.002","article-title":"Factors associated with a delay in the diagnosis of narcolepsy","volume":"5","author":"Morrish","year":"2004","journal-title":"Sleep Med"},{"issue":"2","key":"10.1016\/j.jaut.2014.01.033_bib31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.smrv.2008.04.007","article-title":"Narcolepsy in childhood","volume":"13","author":"Nevsimalova","year":"2009","journal-title":"Sleep Med Rev"},{"issue":"3","key":"10.1016\/j.jaut.2014.01.033_bib32","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ana.22587","article-title":"Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China","volume":"70","author":"Han","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2014.01.033_bib33","article-title":"Decreased incidence of childhood narcolepsy 2 years after the 2009 H1N1 winter flu pandemic","author":"Han","year":"2012","journal-title":"Ann Neurol"},{"issue":"3\u20134","key":"10.1016\/j.jaut.2014.01.033_bib34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000111581","article-title":"A\u00a0case-control study of the environmental risk factors for narcolepsy","volume":"29","author":"Picchioni","year":"2007","journal-title":"Neuroepidemiology"},{"issue":"4","key":"10.1016\/j.jaut.2014.01.033_bib35","first-page":"509","article-title":"Antibodies and neuronal autoimmune disorders of the CNS","volume":"257","author":"Graus","year":"2010","journal-title":"J\u00a0Neurol"},{"issue":"9","key":"10.1016\/j.jaut.2014.01.033_bib36","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0167-5699(93)90244-F","article-title":"Defining criteria for autoimmune diseases (Witebsky's postulates revisited)","volume":"14","author":"Rose","year":"1993","journal-title":"Immunol Today"},{"issue":"216","key":"10.1016\/j.jaut.2014.01.033_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007762","article-title":"CD4+ T cell autoimmunity to Hypocretin\/Orexin and cross-reactivity to a 2009 H1N1 influenza a epitope in narcolepsy","volume":"5","author":"De la Herran-Arita","year":"2013","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.jaut.2014.01.033_bib38","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/ng.372","article-title":"Narcolepsy is strongly associated with the T-cell receptor alpha locus","volume":"41","author":"Hallmayer","year":"2009","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.jaut.2014.01.033_bib39","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1086\/318799","article-title":"Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups","volume":"68","author":"Mignot","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"9","key":"10.1016\/j.jaut.2014.01.033_bib40","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ng.647","article-title":"Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy","volume":"42","author":"Hor","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaut.2014.01.033_bib41","series-title":"Insight: GSK vaccine ingredient scrutinized for narcolepsy clues","author":"Kelland","year":"2013"},{"issue":"11","key":"10.1016\/j.jaut.2014.01.033_bib42","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nri2190","article-title":"The origin and application of experimental autoimmune encephalomyelitis","volume":"7","author":"Baxter","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"4262","key":"10.1016\/j.jaut.2014.01.033_bib43","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1126\/science.968486","article-title":"Genetic composition of a high-yielding influenza A virus recombinant: a vaccine strain against \u201cSwine\u201d influenza","volume":"194","author":"Palese","year":"1976","journal-title":"Science"},{"issue":"9396","key":"10.1016\/j.jaut.2014.01.033_bib44","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(03)14802-7","article-title":"Vaccination and autoimmune disease: what is the evidence?","volume":"362","author":"Wraith","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jaut.2014.01.033_bib45","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/cid\/cit222","article-title":"Lack of association of guillain-barre syndrome with vaccinations","volume":"57","author":"Baxter","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jaut.2014.01.033_bib46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/cid\/cit218","article-title":"Editorial commentary: guillain-barre syndrome and vaccinations","volume":"57","author":"Salmon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaut.2014.01.033_bib47","series-title":"Vaccines","first-page":"1182","article-title":"Technologies for making new vaccines","author":"Ellis","year":"2013"},{"issue":"12","key":"10.1016\/j.jaut.2014.01.033_bib48","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1128\/CVI.00290-09","article-title":"Vaccines: the fourth century","volume":"16","author":"Plotkin","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"9\u201310","key":"10.1016\/j.jaut.2014.01.033_bib49","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0264-410X(99)00271-6","article-title":"DNA and RNA-based vaccines: principles, progress and prospects","volume":"18","author":"Leitner","year":"1999","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.jaut.2014.01.033_bib50","doi-asserted-by":"crossref","first-page":"14604","DOI":"10.1073\/pnas.1209367109","article-title":"Nonviral delivery of self-amplifying RNA vaccines","volume":"109","author":"Geall","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.jaut.2014.01.033_bib51","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nat Rev Genet"},{"issue":"3","key":"10.1016\/j.jaut.2014.01.033_bib52","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/cid\/cir334","article-title":"Clinical applications of DNA vaccines: current progress","volume":"53","author":"Ferraro","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaut.2014.01.033_bib53","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2119\/molmed.2012.00147","article-title":"Novel viral vectored vaccines for the prevention of influenza","volume":"18","author":"Lambe","year":"2012","journal-title":"Mol Med"},{"issue":"10","key":"10.1016\/j.jaut.2014.01.033_bib54","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3855\/jidc.2061","article-title":"Infectious diseases and autoimmunity","volume":"5","author":"Delogu","year":"2011","journal-title":"J\u00a0Infect Dev Ctries"},{"issue":"1","key":"10.1016\/j.jaut.2014.01.033_bib55","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1006\/smim.1997.0100","article-title":"The role of infection in the pathogenesis of autoimmune disease","volume":"10","author":"Rose","year":"1998","journal-title":"Semin Immunol"},{"issue":"5","key":"10.1016\/j.jaut.2014.01.033_bib56","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1172\/JCI119622","article-title":"Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes","volume":"100","author":"Wucherpfennig","year":"1997","journal-title":"J\u00a0Clin Invest"},{"issue":"12","key":"10.1016\/j.jaut.2014.01.033_bib57","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/nm1297-1321","article-title":"More mayhem from molecular mimics","volume":"3","author":"Steinman","year":"1997","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.jaut.2014.01.033_bib58","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1084\/jem.189.8.1275","article-title":"Microbial epitopes act as altered peptide ligands to prevent experimental autoimmune encephalomyelitis","volume":"189","author":"Ruiz","year":"1999","journal-title":"J\u00a0Exp Med"},{"issue":"12","key":"10.1016\/j.jaut.2014.01.033_bib59","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMra020100","article-title":"The effect of infections on susceptibility to autoimmune and allergic diseases","volume":"347","author":"Bach","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"27","key":"10.1016\/j.jaut.2014.01.033_bib60","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1016\/j.vaccine.2011.04.046","article-title":"The safety evaluation of adjuvants during vaccine development: the AS04 experience","volume":"29","author":"Garcon","year":"2011","journal-title":"Vaccine"},{"issue":"49","key":"10.1016\/j.jaut.2014.01.033_bib61","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1016\/j.vaccine.2009.08.101","article-title":"MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database","volume":"27","author":"Pellegrini","year":"2009","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.jaut.2014.01.033_bib62","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1086\/655830","article-title":"AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age","volume":"51","author":"Roman","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaut.2014.01.033_bib63","series-title":"Fendrix: EPAR - product information","author":"GlaxoSmithKline Biologicals","year":"2013"},{"key":"10.1016\/j.jaut.2014.01.033_bib64","doi-asserted-by":"crossref","first-page":"f2375","DOI":"10.1136\/bmj.f2375","article-title":"Is the adjuvant solely to blame?","volume":"346","author":"Tsai","year":"2013","journal-title":"Br Med J"},{"issue":"1","key":"10.1016\/j.jaut.2014.01.033_bib65","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-065X.2010.00974.x","article-title":"Influenza vaccine immunology","volume":"239","author":"Dormitzer","year":"2011","journal-title":"Immunol Rev"},{"issue":"85","key":"10.1016\/j.jaut.2014.01.033_bib66","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002336","article-title":"MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines","volume":"3","author":"Khurana","year":"2011","journal-title":"Sci Transl Med"},{"issue":"7","key":"10.1016\/j.jaut.2014.01.033_bib67","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/INF.0b013e31819d6394","article-title":"Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant","volume":"28","author":"Vesikari","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"16","key":"10.1016\/j.jaut.2014.01.033_bib68","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1016\/j.vaccine.2007.01.025","article-title":"Immunosenescence: role and measurement in influenza vaccine response among the elderly","volume":"25","author":"Targonski","year":"2007","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.jaut.2014.01.033_bib69","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1473-3099(13)70046-X","article-title":"AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial","volume":"13","author":"McElhaney","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.jaut.2014.01.033_bib70","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S1473-3099(13)70038-0","article-title":"AS03-adjuvanted influenza vaccine in elderly people","volume":"13","author":"Ledgerwood","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.jaut.2014.01.033_bib71","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajog.2012.07.007","article-title":"Safety of MF59-adjuvanted A\/H1N1 influenza vaccine in pregnancy: a comparative cohort study","volume":"207","author":"Heikkinen","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaut.2014.01.033_bib72","doi-asserted-by":"crossref","first-page":"f393","DOI":"10.1136\/bmj.f393","article-title":"Influenza A\/H1N1 MF59 adjuvanted vaccine in pregnant women and adverse perinatal outcomes: multicentre study","volume":"346","author":"Rubinstein","year":"2013","journal-title":"Br Med J"},{"issue":"37","key":"10.1016\/j.jaut.2014.01.033_bib73","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1016\/j.vaccine.2011.04.114","article-title":"Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study","volume":"29","author":"Tavares","year":"2011","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.jaut.2014.01.033_bib74","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.jaut.2014.01.033_bib75","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.autrev.2012.05.008","article-title":"Bell's palsy and autoimmunity","volume":"12","author":"Greco","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"9","key":"10.1016\/j.jaut.2014.01.033_bib76","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1056\/NEJMp048006","article-title":"Nasal vaccination, Escherichia coli enterotoxin, and Bell's palsy","volume":"350","author":"Couch","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"2\u20134","key":"10.1016\/j.jaut.2014.01.033_bib77","first-page":"373","article-title":"Influenza vaccination of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)","volume":"13","author":"Stojanovich","year":"2006","journal-title":"Clin Dev Immunol"},{"issue":"1","key":"10.1016\/j.jaut.2014.01.033_bib78","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1386-6532(99)00038-4","article-title":"Acute parvovirus B19 infection in connection with a flare of systemic lupus erythematodes in a female patient","volume":"14","author":"Hemauer","year":"1999","journal-title":"J\u00a0Clin Virol"},{"issue":"6","key":"10.1016\/j.jaut.2014.01.033_bib79","doi-asserted-by":"crossref","first-page":"735","DOI":"10.7326\/0003-4819-88-6-735","article-title":"Influenzal vaccine response in systemic lupus erythematosus","volume":"88","author":"Brodman","year":"1978","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jaut.2014.01.033_bib80","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1620\/tjem.229.29","article-title":"Influenza vaccination in autoimmune rheumatic disease patients","volume":"229","author":"Milanovic","year":"2013","journal-title":"Tohoku J Exp Med"},{"issue":"6","key":"10.1016\/j.jaut.2014.01.033_bib81","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/art.30325","article-title":"Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study","volume":"63","author":"Gabay","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.jaut.2014.01.033_bib82","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.vaccine.2011.11.083","article-title":"Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis","volume":"30","author":"Dell'Era","year":"2012","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.jaut.2014.01.033_bib83","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/acr.20465","article-title":"Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases","volume":"63","author":"Elkayam","year":"2011","journal-title":"Arthritis Care Res Hob"},{"issue":"4","key":"10.1016\/j.jaut.2014.01.033_bib84","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1517\/14712591003724662","article-title":"MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk","volume":"10","author":"Durando","year":"2010","journal-title":"Expert Opin Biol Ther"},{"issue":"5","key":"10.1016\/j.jaut.2014.01.033_bib85","doi-asserted-by":"crossref","first-page":"e1161","DOI":"10.1542\/peds.2010-1920","article-title":"Influenza A\/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months","volume":"127","author":"Esposito","year":"2011","journal-title":"Pediatrics"},{"issue":"45","key":"10.1016\/j.jaut.2014.01.033_bib86","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1016\/j.vaccine.2009.02.004","article-title":"MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination","volume":"27","author":"Vesikari","year":"2009","journal-title":"Vaccine"},{"issue":"43","key":"10.1016\/j.jaut.2014.01.033_bib87","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.1016\/j.vaccine.2011.08.012","article-title":"Different influenza vaccine formulations and adjuvants for childhood influenza vaccination","volume":"29","author":"Esposito","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jaut.2014.01.033_bib88","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/08916930500484757","article-title":"Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea","volume":"39","author":"Kirvan","year":"2006","journal-title":"Autoimmunity"},{"issue":"5","key":"10.1016\/j.jaut.2014.01.033_bib89","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ana.1250","article-title":"Poststreptococcal acute disseminated encephalomyelitis with basal ganglia involvement and auto-reactive antibasal ganglia antibodies","volume":"50","author":"Dale","year":"2001","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.jaut.2014.01.033_bib90","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/PL00000716","article-title":"Molecular mimicry: a critical look at exemplary instances in human diseases","volume":"57","author":"Rose","year":"2000","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jaut.2014.01.033_bib91","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1186\/1471-2458-13-636","article-title":"Influenza vaccination coverage rates among adults before and after the 2009 influenza pandemic and the reasons for non-vaccination in Beijing, China: a cross-sectional study","volume":"13","author":"Wu","year":"2013","journal-title":"BMC Public Health"},{"issue":"11","key":"10.1016\/j.jaut.2014.01.033_bib92","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.3201\/eid1611.100323","article-title":"Estimates of the true number of cases of pandemic (H1N1) 2009, Beijing, China","volume":"16","author":"Wang","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jaut.2014.01.033_bib93","series-title":"A\u00a0review of production technologies for influenza virus vaccine, and their suitability for deployment in developing countries for influenza pandemic preparedness","author":"Hickling","year":"2006"},{"issue":"12","key":"10.1016\/j.jaut.2014.01.033_bib94","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1248\/yakushi.131.1733","article-title":"MF59 adjuvanted seasonal and pandemic influenza vaccines","volume":"131","author":"Tsai","year":"2011","journal-title":"Yakugaku Zasshi"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.jaut.2014.01.033_bib95","doi-asserted-by":"crossref","first-page":"C25","DOI":"10.1016\/j.vaccine.2010.07.021","article-title":"Unmet needs in modern vaccinology: adjuvants to improve the immune response","volume":"28","author":"Leroux-Roels","year":"2010","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.jaut.2014.01.033_bib96","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/jps.23039","article-title":"The role of adjuvant in mediating antigen structure and stability","volume":"101","author":"Braun","year":"2012","journal-title":"J\u00a0Pharm Sci"},{"issue":"5","key":"10.1016\/j.jaut.2014.01.033_bib97","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1586\/14760584.6.5.723","article-title":"GlaxoSmithKline adjuvant systems in vaccines: concepts, achievements and perspectives","volume":"6","author":"Garcon","year":"2007","journal-title":"Expert Rev Vaccines"},{"issue":"29","key":"10.1016\/j.jaut.2014.01.033_bib98","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1016\/j.vaccine.2011.09.061","article-title":"The mechanism of action of MF59-an innately attractive adjuvant formulation","volume":"30","author":"O'Hagan","year":"2012","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.jaut.2014.01.033_bib99","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.vaccine.2011.01.011","article-title":"Adjuvant system AS03 containing alpha-tocopherol modulates innate immune response and leads to improved adaptive immunity","volume":"29","author":"Morel","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jaut.2014.01.033_bib100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pediatrneurol.2007.04.012","article-title":"Children and encephalitis lethargica: a historical review","volume":"37","author":"Vilensky","year":"2007","journal-title":"Pediatr Neurol"},{"issue":"3052","key":"10.1016\/j.jaut.2014.01.033_bib101","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/bmj.1.3052.794","article-title":"Cases resembling encephalitis lethargica occurring during the influenza epidemic","volume":"1","author":"Alexander","year":"1919","journal-title":"Br Med J"},{"key":"10.1016\/j.jaut.2014.01.033_bib102","series-title":"Die encephalitis lethargica","author":"Von Economo","year":"1918"},{"issue":"3050","key":"10.1016\/j.jaut.2014.01.033_bib103","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/bmj.1.3050.733","article-title":"A\u00a0report on two cases of encephalitis lethargica","volume":"1","author":"Brasher","year":"1919","journal-title":"Br Med J"},{"key":"10.1016\/j.jaut.2014.01.033_bib104","first-page":"56","article-title":"Encephalitis lethargica","volume":"12","author":"Buzzard","year":"1919","journal-title":"Proc R Soc Med"},{"issue":"6","key":"10.1016\/j.jaut.2014.01.033_bib105","first-page":"828","article-title":"The late dequelae of encephalitis lethargica and of influenza","volume":"24","author":"Hunter","year":"1931","journal-title":"Can Med Assoc J"},{"issue":"3","key":"10.1016\/j.jaut.2014.01.033_bib106","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/13550280801995445","article-title":"The relationship between encephalitis lethargica and influenza: a critical analysis","volume":"14","author":"McCall","year":"2008","journal-title":"J\u00a0Neurovirol"},{"issue":"10","key":"10.1016\/j.jaut.2014.01.033_bib107","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00702-009-0295-9","article-title":"Encephalitis lethargica and the influenza virus. II. The influenza pandemic of 1918\/19 and encephalitis lethargica: epidemiology and symptoms","volume":"116","author":"Foley","year":"2009","journal-title":"J\u00a0Neural Transm"},{"issue":"5","key":"10.1016\/j.jaut.2014.01.033_bib108","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.mehy.2009.12.012","article-title":"Influenza caused epidemic encephalitis (encephalitis lethargica): the circumstantial evidence and a challenge to the nonbelievers","volume":"74","author":"Maurizi","year":"2010","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.jaut.2014.01.033_bib109","series-title":"Occurrence of narcolepsy with cataplexy among children and adolescents in relation to the H1N1 pandemic and Pandemrix vaccinations \u2013 results of a case inventory study by the MPA in Sweden during 2009-2010. Sweden","author":"Lakemedelsverket Medical Products Agency","year":"2011"},{"key":"10.1016\/j.jaut.2014.01.033_bib110","series-title":"Investigation of an increase in the incidence of narcolepsy in children and adolescents in 2009 and 2010","author":"O'Flanagan","year":"2012"},{"issue":"9","key":"10.1016\/j.jaut.2014.01.033_bib111","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.sleep.2013.03.020","article-title":"Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A","volume":"14","author":"Heier","year":"2013","journal-title":"Sleep Med"},{"issue":"Pt 8","key":"10.1016\/j.jaut.2014.01.033_bib112","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1093\/brain\/awt187","article-title":"Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France","volume":"136","author":"Dauvilliers","year":"2013","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.jaut.2014.01.033_bib113","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0092-8674(00)81107-1","article-title":"Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system","volume":"85","author":"Steinman","year":"1996","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.jaut.2014.01.033_bib114","doi-asserted-by":"crossref","first-page":"7440","DOI":"10.1073\/pnas.92.16.7440","article-title":"Plaque-associated expression of human herpesvirus 6 in multiple sclerosis","volume":"92","author":"Challoner","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.jaut.2014.01.033_bib115","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1128\/iai.62.5.2122-2125.1994","article-title":"Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barre syndrome patients mimic human gangliosides in structure","volume":"62","author":"Aspinall","year":"1994","journal-title":"Infect Immun"},{"issue":"1\u20132","key":"10.1016\/j.jaut.2014.01.033_bib116","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0165-5728(02)00209-6","article-title":"Cross-reactive anti-galactocerebroside antibodies and Mycoplasma pneumoniae infections in Guillain-Barre syndrome","volume":"130","author":"Ang","year":"2002","journal-title":"J\u00a0Neuroimmunol"},{"issue":"8601","key":"10.1016\/j.jaut.2014.01.033_bib117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0140-6736(88)92941-8","article-title":"Association of cytomegalovirus infection with autoimmune type 1 diabetes","volume":"2","author":"Pak","year":"1988","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jaut.2014.01.033_bib118","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ni0402-338","article-title":"Type 1 diabetes: virus infection or autoimmune disease?","volume":"3","author":"Fairweather","year":"2002","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.jaut.2014.01.033_bib119","doi-asserted-by":"crossref","first-page":"725","DOI":"10.7326\/0003-4819-107-5-725","article-title":"The clinical evolution of Lyme arthritis","volume":"107","author":"Steere","year":"1987","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.jaut.2014.01.033_bib120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199401273300401","article-title":"Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis","volume":"330","author":"Nocton","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.jaut.2014.01.033_bib121","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1590\/S0037-86821992000200003","article-title":"The evolution of chronic chagasic cardiopathy. I. The influence of parasitemia","volume":"25","author":"Pereira","year":"1992","journal-title":"Rev Soc Bras Med Trop"},{"issue":"2","key":"10.1016\/j.jaut.2014.01.033_bib122","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4269\/ajtmh.2003.68.242","article-title":"Analysis of the presence of Trypanosoma cruzi in the heart tissue of three patients with chronic Chagas' heart disease","volume":"68","author":"Elias","year":"2003","journal-title":"Am J Trop Med Hyg"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841114000389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841114000389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:09:21Z","timestamp":1760256561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841114000389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":122,"alternative-id":["S0896841114000389"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2014.01.033","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: What is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2014.01.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}